FR2457101A1 - Forme d'administration orale de l'ethynyloestradiol - Google Patents

Forme d'administration orale de l'ethynyloestradiol

Info

Publication number
FR2457101A1
FR2457101A1 FR8011221A FR8011221A FR2457101A1 FR 2457101 A1 FR2457101 A1 FR 2457101A1 FR 8011221 A FR8011221 A FR 8011221A FR 8011221 A FR8011221 A FR 8011221A FR 2457101 A1 FR2457101 A1 FR 2457101A1
Authority
FR
France
Prior art keywords
ethynyloestradiol
oral administration
alkylsulphonic
ester
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR8011221A
Other languages
English (en)
Inventor
Claus Claussen
Klaus-Henning Chemnitius
Annemarie Naumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jenapharm GmbH and Co KG
Original Assignee
Jenapharm GmbH and Co KG
VEB Jenapharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm GmbH and Co KG, VEB Jenapharm filed Critical Jenapharm GmbH and Co KG
Publication of FR2457101A1 publication Critical patent/FR2457101A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FORME MEDICAMENTEUSE POUR ADMINISTRATION ORALE CONTENANT UN ESTER ALKYLSULFONIQUE DE L'ETHYNYLOESTRADIOL. CETTE FORME D'ADMINISTRATION CONSISTE EN UNE CAPSULE QUI CONTIENT UN ESTER ALKYLSULFONIQUE DE L'ETHYNYLOESTRADIOL ET UN SOLVANT LIPOPHILE A UNE CONCENTRATION DE 1 A 20MG AU MAXIMUM D'ESTER ALKYLSULFONIQUE DE L'ETHYNYLOESTRADIOL PAR ML DE SOLVANT, AVEC UNE PETITE QUANTITE D'UN CO-SOLVANT.
FR8011221A 1979-05-21 1980-05-20 Forme d'administration orale de l'ethynyloestradiol Pending FR2457101A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD79213022A DD148185A1 (de) 1979-05-21 1979-05-21 Verfahren zur herstellung einer oral applizierbaren arzneiform

Publications (1)

Publication Number Publication Date
FR2457101A1 true FR2457101A1 (fr) 1980-12-19

Family

ID=5518244

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8011221A Pending FR2457101A1 (fr) 1979-05-21 1980-05-20 Forme d'administration orale de l'ethynyloestradiol

Country Status (6)

Country Link
JP (1) JPS55154914A (fr)
DD (1) DD148185A1 (fr)
DE (1) DE3007251A1 (fr)
FR (1) FR2457101A1 (fr)
GB (1) GB2048672A (fr)
IT (1) IT1145677B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59004243D1 (de) 1990-06-14 1994-02-24 Henning Berlin Gmbh Flüssig befüllte Steckkapselpräparate.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1949095A1 (de) * 1968-10-04 1970-09-24 Jenapharm Veb Steroidester
FR2312256A1 (fr) * 1975-05-30 1976-12-24 Akzo Nv Nouveaux esters-17b d'oestradiol et compositions therapeutiques renfermant des esters-17b d'oestradiol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1949095A1 (de) * 1968-10-04 1970-09-24 Jenapharm Veb Steroidester
FR2312256A1 (fr) * 1975-05-30 1976-12-24 Akzo Nv Nouveaux esters-17b d'oestradiol et compositions therapeutiques renfermant des esters-17b d'oestradiol

Also Published As

Publication number Publication date
DE3007251A1 (de) 1980-12-04
IT1145677B (it) 1986-11-05
JPS55154914A (en) 1980-12-02
DD148185A1 (de) 1981-05-13
IT8048714A0 (it) 1980-05-16
GB2048672A (en) 1980-12-17

Similar Documents

Publication Publication Date Title
FR2436140A1 (fr) Derives de 1 a-hydroxy cyclovitamines du groupe d et leur preparation
FR2377376A1 (fr) Derives d'hexahydroterphenyle et leur application en tant que cristaux liquides
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
FR2696461B1 (fr) Nouveaux dérivés d'analogues du taxol, leur préparation et les compositions qui les contiennent.
FR2439182A1 (fr) Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments
BE802202A (fr) Preparations solides, de forme stable pour la desodorisation de l'air contenant une substance active volatile
FR2321892A1 (fr) Preparations pharmaceutiques pour l'administration orale renfermant un ester-17b de nandrolone et nouveaux esters-17b de nandrolone
FR2411839B1 (fr) Derives de l'acide cephalosporanique, procedes pour leur preparation et composition pharmaceutique les contenant
FR2370753A1 (fr) Derives du glucofurannose et leur application therapeutique
FR2376134A1 (fr) Derives de 6-oxo-prostaglandines, leur procede de preparation et medicaments en contenant
SE8600632D0 (sv) Novel pharmaceutical composition
FR2363330A1 (fr) Medicament destine a reduire la fertilite chez les mammiferes
BE847943A (fr) Nouveau derive de l'acide retinoique totalement trans et composition pharmaceutique contenant ledit derive,
BE906034A (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
FR2552M (fr) Nouvelles compositions de vitamines renfermant une forme stabilisée de l'acide pantothénique.
KR920012110A (ko) 산화형 글루타티온 알킬 에스테르
FR2408578A1 (fr) Alkoxylates d'ester-diols modifies par un anhydride et leur application dans des formulations de revetement
FR2457101A1 (fr) Forme d'administration orale de l'ethynyloestradiol
KR880008801A (ko) 비경구 투여용 용액제
FR2423222A1 (fr) Composition pharmaceutique contenant un derive de xanthine
FR2453152A1 (fr) Nouveaux derives de prostaglandine et medicament les contenant
FR2441617A1 (fr) Nouveaux derives de s-triazine, leur procede de preparation et compositions pharmaceutiques les contenant
FR2390424A1 (fr) Nouveaux derives d'amides de l'acide phenylacetique substitues, leur application en tant que medicament et leur application
KR920701220A (ko) 신규의 복핵 백금 착체 및 이를 유효성분으로하는 항종양제
FR2405712A1 (fr) Composes de la serie des pregnanes avec une fonction oxygene en position 19, procede de preparation et preparations pharmaceutiques qui contiennent ces composes